Home > Insider Trading > Filing (0001628280-24-040521)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1104506	Insmed Inc	INSM	Pharmaceutical Preparations (2834)	541972729

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1796960	M.d. Martina Flammer	700 Us Highway 202/206 Bridgewater NJ 08807	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2024-09-12	635	$34.03	106,769	No	4	M	Direct
Common Stock	Disposition	2024-09-12	635	$74.92	106,134	No	4	S	Direct
Common Stock	Acquisiton	2024-09-13	26,969	$34.03	133,103	No	4	M	Direct
Common Stock	Disposition	2024-09-13	26,969	$74.90	106,134	No	4	S	Direct
Common Stock	Acquisiton	2024-09-16	13,436	$34.03	119,570	No	4	M	Direct
Common Stock	Disposition	2024-09-16	13,436	$74.92	106,134	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2024-09-12	635	$0.00	635	$34.03
Common Stock	Stock Option (right to buy)	Disposition	2024-09-13	26,969	$0.00	26,969	$34.03
Common Stock	Stock Option (right to buy)	Disposition	2024-09-16	13,436	$0.00	13,436	$34.03

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
54,085	2031-01-07	No	4	M	Direct
27,116	2031-01-07	No	4	M	Direct
13,680	2031-01-07	No	4	M	Direct

Footnotes

This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
This is the weighted average sales price representing 635 shares sold at prices ranging from $74.90 to $74.93 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
This is the weighted average sales price representing 13,436 shares sold at prices ranging from $74.90 to $75.17 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
The options become exercisable based on the following vesting schedule: 25% vest on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.